Authors


Jim Kelly

Latest:

Jim Kelly Explains How Nurses Inspire Him

Jim Kelly, NFL Hall of Famer, discusses how nurses inspire him.


Deborah Lee, MSN, RN, FNP, ACNP-BC

Latest:

Chemotherapy-Induced Cardiomyopathy

Chemotherapy-induced cardiotoxicity is defined as a poisonous or detrimental effect upon the heart that can delay cancer treatment, decrease survival, and increase morbidity.


Jason Luke, MD

Latest:

What's Next for Advanced Melanoma?

Jason Luke, MD, assistant professor at the University of Chicago Medicine, discusses what he hopes the future of advanced melanoma treatment will look like.


Don Henry

Latest:

Antiperspirants Not Increasing Skin Irritation for Patients with Breast Cancer

A recent study has found that there may be no risk of increasing skin irritation by using antiperspirants for patients with breast cancer undergoing radiation.


Angie Meillier, RN, MS, CPPM

Latest:

Angie Meillier on the Importance of Timing When Communicating

Angie Meillier, RN, MS, CPPM, of Allina Health System, explains why nurses should be sure that patients are ready to hear and understand specific information.


Harold P. Freeman, MD

Latest:

Dr. Freeman Describes Patient Navigation

Dr. Harold P. Freeman from Ralph Lauren Center for Cancer Care and Prevention Describes Patient Navigation


Brian I. Rini, MD

Latest:

Dr. Rini Describes Axitinib's and Sorafenib's Side Effects

Dr. Brian I. Rini from the Taussig Cancer Institute Describes Axitinib's and Sorafenib's Side Effects


Kerry Rogers, MD

Latest:

Addressing the Unmet Needs of Patients with Hairy Cell Leukemia

For patients with hairy cell leukemia, it's complications after treatment that can be life-threatening.


Ellen Rice Tichich, MFA, MSN, RN-BC

Latest:

Caring for the Geriatric Patient: What Oncology Nurses Need to Know

Oncology nurses must consider many factors when treating geriatric patients, from drug-drug interactions to treatment education and functional age.


Mary Gullatte, PhD, RN, APRN

Latest:

Mary Gullatte on Managing Compassion Fatigue

ONS President Mary Gullatte Discusses Ways to Manage Compassion Fatigue for Oncology Nurses.


Jamie Myers, PhD, RN

Latest:

Jamie Myers Describes the Design of Her CRCI Study

Jamie Myers Describes the Design of Her Chemotherapy-Related Cognitive Impairment Study


Traci L. Hedrick, MD, MS

Latest:

A Better Way to Prepare Patients for CRC Surgery and Shorten Recovery Time

At the University of Virginia (UVA) Health System, the enhanced recovery after surgery (ERAS) program in colorectal cancer has improved outcomes of patients after procedures and reduced hospital costs.


By Julie Beck, RN, MSN, MPH, APRN-BC

Latest:

Nurse-Driven Website Empowers Nurses to Improve Patient Care

Improving communication, building relationships, coordinating activities among units, and engaging staff members are not only ways to create a more positive working environment, they are critical for maintaining patient safety.


Carey K. Anders, MD

Latest:

Treatment Approaches for Brain Metastases in Breast Cancer

An expert gives an overview of the different treatment approaches for patients with breast cancer that has metastasized to their brain.


Jane M. Armer, RN, PhD

Latest:

Jane Armer on Lymphedema Symptoms and Treatments

Jane Armer director of ALFP Discusses Lymphedema Symptoms and Treatments


Danielle Hicks

Latest:

Danielle Hicks Discusses the Bonnie Addario Lung Cancer Foundation Lung Cancer Living Room Program

Danielle Hicks, director, Patient Services and Support, Bonnie J. Addario Lung Cancer Foundation, discusses the lung cancer living room program



Anitra Engebretson

Latest:

Connect Your Patients With Pancreatic Cancer Clinical Trial Options

Finding treatment options, helping patients, and contributing to clinical research just got easier.


Beth Thompson, RN, MSN, CBCN

Latest:

No words: Can Silence Be a Part of Healing?

Maybe in these most profound moments after a diagnosis of breast cancer, we are called to be still.


Supriya Mohile, MD

Latest:

Supriya Mohile on Lack of Representation of Geriatric Patients in Clinical Trials

Supriya Mohile discusses the disparity that can exist between patients in clinical trials and patients that providers experience in the real world.


Mario Szonl, MD

Latest:

New Combos Are Coming to the Melanoma Space

The future of melanoma treatment will include many combinations, explained Mario Sznol, MD, professor of medicine and co-leader of cancer immunology at the Yale Cancer Center.


Frederick Locke, MD

Latest:

CAR T-Cell Therapy: Great Results, Major Toxicities

CAR T-cell therapy is producing durable responses in many subgroups of patients. However, the treatment could also come with some major adverse events.


DANIEL KARLIN, MD

Latest:

Opioid-Induced Nausea and Vomiting: What the Oncology Nurse Should Know

Up to 40% of patients with cancer who take opioids experience nausea and vomiting.


Mike Hennessy, Sr, Chairman

Latest:

Fall Into Better Health and Financial Practices

A note from the chairman and founder about the October 2021 issue of Oncology Nursing News®


Robert Antbacka, MD, CM

Latest:

Robert Andtbacka on Caring for a Patient's Emotions and the Family

Robert Andtbacka, MD, CM, notes the importance of treating the patient’s emotional needs, as well as the needs of the patient’s family.


Susan Sprague Yeske

Latest:

Oncology Nutritionists: Should cancer care teams include dietary experts?

Early screening and comprehensive assessment of risk for malnutrition is increasingly recognized as imperative in the development of standards of quality of care in oncology practices.


Jennifer Levine, MD

Latest:

Jennifer Levine on Fertility Challenges in Survivors of Childhood Cancer

Jennifer Levine, MD, Columbia University Medical Center, discusses fertility issues that adult survivors of childhood cancer often face.


Destiny Cromer, ANP-BC, AOCNP

Latest:

Destiny Cromer on the Impact of Patient Understanding on Treatment Decisions

Destiny Cromer, ANP-BC, AOCNP, of Texas Oncology, discusses why it is so important that a patient fully understands their prognosis and the intent of their treatment.


Sancy Leachman, MD, PhD

Latest:

Sancy Leachman on Patients at High Risk for Melanoma

Sancy Leachman, MD, PhD, professor and chair, Department of Dermatology, director, Melanoma Research Program, Knight Cancer Institute, Oregon Health & Science University, discusses patients who are at high risk for developing melanoma.


Ryan J. Sullivan, MD

Latest:

Risks Versus Benefits in Combining Immunotherapies

Combining two checkpoint blockades can be very efficacious in treating metastatic melanoma, but the benefits come with increased risk of adverse events, too.

© 2024 MJH Life Sciences

All rights reserved.